1. Home
  2. ENVX vs SUPN Comparison

ENVX vs SUPN Comparison

Compare ENVX & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVX
  • SUPN
  • Stock Information
  • Founded
  • ENVX 2006
  • SUPN 2005
  • Country
  • ENVX United States
  • SUPN United States
  • Employees
  • ENVX N/A
  • SUPN N/A
  • Industry
  • ENVX Industrial Machinery/Components
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENVX Miscellaneous
  • SUPN Health Care
  • Exchange
  • ENVX Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • ENVX 2.4B
  • SUPN 2.6B
  • IPO Year
  • ENVX N/A
  • SUPN 2012
  • Fundamental
  • Price
  • ENVX $12.39
  • SUPN $52.62
  • Analyst Decision
  • ENVX Strong Buy
  • SUPN Strong Buy
  • Analyst Count
  • ENVX 9
  • SUPN 3
  • Target Price
  • ENVX $18.11
  • SUPN $62.67
  • AVG Volume (30 Days)
  • ENVX 8.4M
  • SUPN 725.2K
  • Earning Date
  • ENVX 11-05-2025
  • SUPN 11-04-2025
  • Dividend Yield
  • ENVX N/A
  • SUPN N/A
  • EPS Growth
  • ENVX N/A
  • SUPN 1411.53
  • EPS
  • ENVX N/A
  • SUPN 1.14
  • Revenue
  • ENVX $26,600,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • ENVX $44.20
  • SUPN $7.31
  • Revenue Next Year
  • ENVX $211.99
  • SUPN $21.87
  • P/E Ratio
  • ENVX N/A
  • SUPN $46.18
  • Revenue Growth
  • ENVX 60.04
  • SUPN 5.55
  • 52 Week Low
  • ENVX $4.61
  • SUPN $29.16
  • 52 Week High
  • ENVX $16.49
  • SUPN $53.28
  • Technical
  • Relative Strength Index (RSI)
  • ENVX 56.14
  • SUPN 73.21
  • Support Level
  • ENVX $10.84
  • SUPN $49.95
  • Resistance Level
  • ENVX $12.69
  • SUPN $52.15
  • Average True Range (ATR)
  • ENVX 0.95
  • SUPN 1.35
  • MACD
  • ENVX -0.11
  • SUPN 0.16
  • Stochastic Oscillator
  • ENVX 45.99
  • SUPN 90.19

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: